We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ASP METHODOLOGY LIKELY TO BE ADOPTED BY STATES, PRIVATE INSURERS
ASP METHODOLOGY LIKELY TO BE ADOPTED BY STATES, PRIVATE INSURERS
April 20, 2004
Despite continuing confusion in the industry about how the average sales price (ASP) of drugs will be calculated for the purpose of setting Medicare Part B reimbursements, drugmakers should expect to see the new ASP methodology spread to state Medicaid programs and commercial payers, according to drug price-reporting experts.